N 
16.11
+3.27%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue, before interest expense
$29.48bn
FY2016FY2025
Net income
$5.83bn
FY2016FY2025
Total assets
$714.55bn
FY2016FY2025
Shareholders' equity
$42.60bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | $29.48bn | $28.57bn | $33.44bn | $21.81bn | $16.26bn | $17.67bn | $20.32bn | $21.25bn | $19.94bn | $20.14bn |
| Operating income | $7.71bn | $6.20bn | $8.34bn | $6.93bn | $5.19bn | −$746.9m | $5.38bn | $4.54bn | $3.02bn | −$5.51bn |
| Net income | $5.83bn | $4.80bn | $6.26bn | $4.85bn | $4.41bn | −$502.4m | $4.78bn | $2.92bn | $1.99bn | −$7.10bn |
| Diluted earnings per share | 2.88 | 2.34 | 2.28 | 0.50 | 1.66 | -0.18 | 1.70 | 1.04 | 0.71 | -2.60 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $714.55bn | $956.17bn | $935.49bn | $972.47bn | $1.06trn | $1.08trn | $976.50bn | $937.60bn | $996.78bn | $1.08trn |
| Cash and short-term investments | $98.23bn | $144.42bn | $157.30bn | $195.91bn | $240.07bn | $168.13bn | $105.15bn | $120.71bn | $134.18bn | $101.33bn |
| Total liabilities | $671.94bn | $902.99bn | $885.27bn | $923.18bn | $11.38bn | $13.45bn | $13.48bn | $874.81bn | $930.48bn | $1.01trn |
| Debt | $60.25bn | $71.57bn | $158.39bn | $141.60bn | $149.27bn | $108.23bn | $134.15bn | $57.90bn | $44.51bn | $52.55bn |
| Shareholders' equity | $42.60bn | $53.14bn | $50.18bn | $49.29bn | $1.04trn | $1.07trn | $963.02bn | $61.77bn | $65.27bn | $65.65bn |
| Shares outstanding | 2,025m | 2,053m | 2,750m | 9,708m | 2,651m | 2,812m | 2,812m | 2,805m | 2,786m | 2,731m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | $10.62bn | $9.97bn | $7.39bn | $10.19bn | $7.25bn | $9.82bn | $9.80bn | $9.84bn |
| Operating income | $3.10bn | $2.75bn | $1.94bn | $2.95bn | $1.77bn | $2.45bn | $2.02bn | $2.26bn |
| Net income | $2.28bn | $2.03bn | $1.48bn | $2.27bn | $1.33bn | $1.81bn | $1.79bn | $1.68bn |
| Diluted earnings per share | 1.13 | 1.01 | 0.73 | 1.12 | 0.66 | 0.90 | 0.87 | 0.82 |
| Total assets | $1.01trn | $1.01trn | $714.55bn | $980.01bn | $730.78bn | $958.93bn | $956.17bn | $961.45bn |
| Cash and short-term investments | $128.57bn | $183.38bn | $98.23bn | $191.16bn | $112.23bn | $205.74bn | $144.42bn | $216.19bn |
| Debt | $43.45bn | — | $60.34bn | $149.60bn | $46.27bn | $93.07bn | $91.99bn | $102.65bn |
| Shareholders' equity | $59.10bn | $58.96bn | $42.60bn | $57.21bn | $41.96bn | $56.17bn | $53.14bn | $51.99bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 10.6% | 10.8% | 3.1% |
| Operating income | 3.6% | — | — |
| Net income | 6.4% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 24.0% | 25.8% | 22.8% | 14.9% |
| Net margin | 18.3% | 19.2% | 17.4% | 10.4% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 6.1 | 4.3 | 2.5 | 12.9 | 3.7 | -25.3 | 3.8 | 5.4 | 10.7 | -2.1 |
| Price to sales | 1.2 | 0.7 | 0.5 | 2.9 | 1.0 | 0.7 | 0.9 | 0.7 | 1.1 | 0.8 |
Market value over time
31 Oct 2016 to 11 Sept 2026, in USD
$27.00bn$38.04bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 71% | 77% | -11% | 10% | 41% | -35% | 20% | -30% | 33% | -36% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.